img

Global 3D Printed Drugs Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global 3D Printed Drugs Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. 
The global 3D Printed Drugs market size was US$ 224.3 million in 2022 and is forecast to a readjusted size of US$ 297.8 million by 2034 with a CAGR of 3.7% during the forecast period 2024-2034.
Spritam is the only 3D printed drug which has received FDA approval. This drug was first available in the market in 2016, and can be used to treat epilepsy. 
In terms of sales (consumption) side, this report focuses on the sales of 3D Printed Drugs by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global 3D Printed Drugs market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global 3D Printed Drugs market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Aprecia Pharmaceuticals
GlaxoSmithKline
Revolution Medicines
FabRX
By Type
Spritam
Others
By Application
Children
Elderly
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of 3D Printed Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of 3D Printed Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, 3D Printed Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 3D Printed Drugs Definition
1.2 Market by Type
1.2.1 Global 3D Printed Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Spritam
1.2.3 Others
1.3 Market Segment by Application
1.3.1 Global 3D Printed Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Children
1.3.3 Elderly
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global 3D Printed Drugs Sales
2.1 Global 3D Printed Drugs Revenue Estimates and Forecasts 2018-2034
2.2 Global 3D Printed Drugs Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global 3D Printed Drugs Revenue by Region
2.3.1 Global 3D Printed Drugs Revenue by Region (2018-2024)
2.3.2 Global 3D Printed Drugs Revenue by Region (2024-2034)
2.4 Global 3D Printed Drugs Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global 3D Printed Drugs Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global 3D Printed Drugs Sales Quantity by Region
2.6.1 Global 3D Printed Drugs Sales Quantity by Region (2018-2024)
2.6.2 Global 3D Printed Drugs Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global 3D Printed Drugs Sales Quantity by Manufacturers
3.1.1 Global 3D Printed Drugs Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global 3D Printed Drugs Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by 3D Printed Drugs Sales in 2022
3.2 Global 3D Printed Drugs Revenue by Manufacturers
3.2.1 Global 3D Printed Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global 3D Printed Drugs Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by 3D Printed Drugs Revenue in 2022
3.3 Global 3D Printed Drugs Sales Price by Manufacturers
3.4 Global Key Players of 3D Printed Drugs, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global 3D Printed Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of 3D Printed Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of 3D Printed Drugs, Product Offered and Application
3.8 Global Key Manufacturers of 3D Printed Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global 3D Printed Drugs Sales Quantity by Type
4.1.1 Global 3D Printed Drugs Historical Sales Quantity by Type (2018-2024)
4.1.2 Global 3D Printed Drugs Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global 3D Printed Drugs Sales Quantity Market Share by Type (2018-2034)
4.2 Global 3D Printed Drugs Revenue by Type
4.2.1 Global 3D Printed Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global 3D Printed Drugs Forecasted Revenue by Type (2024-2034)
4.2.3 Global 3D Printed Drugs Revenue Market Share by Type (2018-2034)
4.3 Global 3D Printed Drugs Price by Type
4.3.1 Global 3D Printed Drugs Price by Type (2018-2024)
4.3.2 Global 3D Printed Drugs Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global 3D Printed Drugs Sales Quantity by Application
5.1.1 Global 3D Printed Drugs Historical Sales Quantity by Application (2018-2024)
5.1.2 Global 3D Printed Drugs Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global 3D Printed Drugs Sales Quantity Market Share by Application (2018-2034)
5.2 Global 3D Printed Drugs Revenue by Application
5.2.1 Global 3D Printed Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global 3D Printed Drugs Forecasted Revenue by Application (2024-2034)
5.2.3 Global 3D Printed Drugs Revenue Market Share by Application (2018-2034)
5.3 Global 3D Printed Drugs Price by Application
5.3.1 Global 3D Printed Drugs Price by Application (2018-2024)
5.3.2 Global 3D Printed Drugs Price Forecast by Application (2024-2034)
6 North America
6.1 North America 3D Printed Drugs Sales by Company
6.1.1 North America 3D Printed Drugs Revenue by Company (2018-2024)
6.1.2 North America 3D Printed Drugs Sales Quantity by Company (2018-2024)
6.2 North America 3D Printed Drugs Market Size by Type
6.2.1 North America 3D Printed Drugs Sales Quantity by Type (2018-2034)
6.2.2 North America 3D Printed Drugs Revenue by Type (2018-2034)
6.3 North America 3D Printed Drugs Market Size by Application
6.3.1 North America 3D Printed Drugs Sales Quantity by Application (2018-2034)
6.3.2 North America 3D Printed Drugs Revenue by Application (2018-2034)
6.4 North America 3D Printed Drugs Market Size by Country
6.4.1 North America 3D Printed Drugs Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America 3D Printed Drugs Revenue by Country (2018-2034)
6.4.3 North America 3D Printed Drugs Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe 3D Printed Drugs Sales by Company
7.1.1 Europe 3D Printed Drugs Sales Quantity by Company (2018-2024)
7.1.2 Europe 3D Printed Drugs Revenue by Company (2018-2024)
7.2 Europe 3D Printed Drugs Market Size by Type
7.2.1 Europe 3D Printed Drugs Sales Quantity by Type (2018-2034)
7.2.2 Europe 3D Printed Drugs Revenue by Type (2018-2034)
7.3 Europe 3D Printed Drugs Market Size by Application
7.3.1 Europe 3D Printed Drugs Sales Quantity by Application (2018-2034)
7.3.2 Europe 3D Printed Drugs Revenue by Application (2018-2034)
7.4 Europe 3D Printed Drugs Market Size by Country
7.4.1 Europe 3D Printed Drugs Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe 3D Printed Drugs Revenue by Country (2018-2034)
7.4.3 Europe 3D Printed Drugs Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China 3D Printed Drugs Sales by Company
8.1.1 China 3D Printed Drugs Sales Quantity by Company (2018-2024)
8.1.2 China 3D Printed Drugs Revenue by Company (2018-2024)
8.2 China 3D Printed Drugs Market Size by Type
8.2.1 China 3D Printed Drugs Sales Quantity by Type (2018-2034)
8.2.2 China 3D Printed Drugs Revenue by Type (2018-2034)
8.3 China 3D Printed Drugs Market Size by Application
8.3.1 China 3D Printed Drugs Sales Quantity by Application (2018-2034)
8.3.2 China 3D Printed Drugs Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC 3D Printed Drugs Sales by Company
9.1.1 APAC 3D Printed Drugs Sales Quantity by Company (2018-2024)
9.1.2 APAC 3D Printed Drugs Revenue by Company (2018-2024)
9.2 APAC 3D Printed Drugs Market Size by Type
9.2.1 APAC 3D Printed Drugs Sales Quantity by Type (2018-2034)
9.2.2 APAC 3D Printed Drugs Revenue by Type (2018-2034)
9.3 APAC 3D Printed Drugs Market Size by Application
9.3.1 APAC 3D Printed Drugs Sales Quantity by Application (2018-2034)
9.3.2 APAC 3D Printed Drugs Revenue by Application (2018-2034)
9.4 APAC 3D Printed Drugs Market Size by Region
9.4.1 APAC 3D Printed Drugs Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC 3D Printed Drugs Revenue by Region (2018-2034)
9.4.3 APAC 3D Printed Drugs Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America 3D Printed Drugs Sales by Company
10.1.1 Middle East, Africa and Latin America 3D Printed Drugs Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America 3D Printed Drugs Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America 3D Printed Drugs Market Size by Type
10.2.1 Middle East, Africa and Latin America 3D Printed Drugs Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America 3D Printed Drugs Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America 3D Printed Drugs Market Size by Application
10.3.1 Middle East, Africa and Latin America 3D Printed Drugs Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America 3D Printed Drugs Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America 3D Printed Drugs Market Size by Country
10.4.1 Middle East, Africa and Latin America 3D Printed Drugs Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America 3D Printed Drugs Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America 3D Printed Drugs Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Aprecia Pharmaceuticals
11.1.1 Aprecia Pharmaceuticals Company Information
11.1.2 Aprecia Pharmaceuticals Overview
11.1.3 Aprecia Pharmaceuticals 3D Printed Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Aprecia Pharmaceuticals 3D Printed Drugs Products and Services
11.1.5 Aprecia Pharmaceuticals 3D Printed Drugs SWOT Analysis
11.1.6 Aprecia Pharmaceuticals Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline 3D Printed Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 GlaxoSmithKline 3D Printed Drugs Products and Services
11.2.5 GlaxoSmithKline 3D Printed Drugs SWOT Analysis
11.2.6 GlaxoSmithKline Recent Developments
11.3 Revolution Medicines
11.3.1 Revolution Medicines Company Information
11.3.2 Revolution Medicines Overview
11.3.3 Revolution Medicines 3D Printed Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Revolution Medicines 3D Printed Drugs Products and Services
11.3.5 Revolution Medicines 3D Printed Drugs SWOT Analysis
11.3.6 Revolution Medicines Recent Developments
11.4 FabRX
11.4.1 FabRX Company Information
11.4.2 FabRX Overview
11.4.3 FabRX 3D Printed Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 FabRX 3D Printed Drugs Products and Services
11.4.5 FabRX 3D Printed Drugs SWOT Analysis
11.4.6 FabRX Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 3D Printed Drugs Value Chain Analysis
12.2 3D Printed Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 3D Printed Drugs Production Mode & Process
12.4 3D Printed Drugs Sales and Marketing
12.4.1 3D Printed Drugs Sales Channels
12.4.2 3D Printed Drugs Distributors
12.5 3D Printed Drugs Customers
13 Market Dynamics
13.1 3D Printed Drugs Industry Trends
13.2 3D Printed Drugs Market Drivers
13.3 3D Printed Drugs Market Challenges
13.4 3D Printed Drugs Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global 3D Printed Drugs Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Spritam
Table 3. Major Manufacturers of Others
Table 4. Global 3D Printed Drugs Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global 3D Printed Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global 3D Printed Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global 3D Printed Drugs Revenue Market Share by Region (2018-2024)
Table 8. Global 3D Printed Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global 3D Printed Drugs Revenue Market Share by Region (2024-2034)
Table 10. Global 3D Printed Drugs Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 11. Global 3D Printed Drugs Sales by Region (2018-2024) & (K Units)
Table 12. Global 3D Printed Drugs Sales Market Share by Region (2018-2024)
Table 13. Global 3D Printed Drugs Sales by Region (2024-2034) & (K Units)
Table 14. Global 3D Printed Drugs Sales Market Share by Region (2024-2034)
Table 15. Global 3D Printed Drugs Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 16. Global 3D Printed Drugs Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global 3D Printed Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global 3D Printed Drugs Revenue Share by Manufacturers (2018-2024)
Table 19. Global 3D Printed Drugs Price by Manufacturers 2018-2024 (USD/Unit)
Table 20. Global Key Players of 3D Printed Drugs, Industry Ranking, 2021 VS 2022
Table 21. Global 3D Printed Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global 3D Printed Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 3D Printed Drugs as of 2022)
Table 23. Global Key Manufacturers of 3D Printed Drugs, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of 3D Printed Drugs, Product Offered and Application
Table 25. Global Key Manufacturers of 3D Printed Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global 3D Printed Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 28. Global 3D Printed Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global 3D Printed Drugs Sales Quantity Share by Type (2018-2024)
Table 30. Global 3D Printed Drugs Sales Quantity Share by Type (2024-2034)
Table 31. Global 3D Printed Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global 3D Printed Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global 3D Printed Drugs Revenue Share by Type (2018-2024)
Table 34. Global 3D Printed Drugs Revenue Share by Type (2024-2034)
Table 35. 3D Printed Drugs Price by Type (2018-2024) & (USD/Unit)
Table 36. Global 3D Printed Drugs Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global 3D Printed Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 38. Global 3D Printed Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global 3D Printed Drugs Sales Quantity Share by Application (2018-2024)
Table 40. Global 3D Printed Drugs Sales Quantity Share by Application (2024-2034)
Table 41. Global 3D Printed Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global 3D Printed Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global 3D Printed Drugs Revenue Share by Application (2018-2024)
Table 44. Global 3D Printed Drugs Revenue Share by Application (2024-2034)
Table 45. 3D Printed Drugs Price by Application (2018-2024) & (USD/Unit)
Table 46. Global 3D Printed Drugs Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America 3D Printed Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America 3D Printed Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 49. North America 3D Printed Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 50. North America 3D Printed Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America 3D Printed Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America 3D Printed Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America 3D Printed Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 54. North America 3D Printed Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America 3D Printed Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America 3D Printed Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America 3D Printed Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America 3D Printed Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America 3D Printed Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America 3D Printed Drugs Sales Quantity by Country (2018-2024) & (K Units)
Table 61. North America 3D Printed Drugs Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe 3D Printed Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 63. Europe 3D Printed Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe 3D Printed Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 65. Europe 3D Printed Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe 3D Printed Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe 3D Printed Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe 3D Printed Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 69. Europe 3D Printed Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe 3D Printed Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe 3D Printed Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe 3D Printed Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe 3D Printed Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe 3D Printed Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe 3D Printed Drugs Sales Quantity by Country (2018-2024) & (K Units)
Table 76. Europe 3D Printed Drugs Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China 3D Printed Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 78. China 3D Printed Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 79. China 3D Printed Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 80. China 3D Printed Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China 3D Printed Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 82. China 3D Printed Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 83. China 3D Printed Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 84. China 3D Printed Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China 3D Printed Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 86. China 3D Printed Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC 3D Printed Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 88. APAC 3D Printed Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC 3D Printed Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 90. APAC 3D Printed Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC 3D Printed Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC 3D Printed Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC 3D Printed Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 94. APAC 3D Printed Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC 3D Printed Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC 3D Printed Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC 3D Printed Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC 3D Printed Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC 3D Printed Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC 3D Printed Drugs Sales Quantity by Region (2018-2024) & (K Units)
Table 101. APAC 3D Printed Drugs Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America 3D Printed Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America 3D Printed Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America 3D Printed Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America 3D Printed Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America 3D Printed Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America 3D Printed Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America 3D Printed Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America 3D Printed Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America 3D Printed Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America 3D Printed Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America 3D Printed Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America 3D Printed Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America 3D Printed Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America 3D Printed Drugs Sales Quantity by Country (2018-2024) & (K Units)
Table 116. Middle East, Africa and Latin America 3D Printed Drugs Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Aprecia Pharmaceuticals Company Information
Table 118. Aprecia Pharmaceuticals Description and Overview
Table 119. Aprecia Pharmaceuticals 3D Printed Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 120. Aprecia Pharmaceuticals 3D Printed Drugs Product and Services
Table 121. Aprecia Pharmaceuticals 3D Printed Drugs SWOT Analysis
Table 122. Aprecia Pharmaceuticals Recent Developments
Table 123. GlaxoSmithKline Company Information
Table 124. GlaxoSmithKline Description and Overview
Table 125. GlaxoSmithKline 3D Printed Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 126. GlaxoSmithKline 3D Printed Drugs Product and Services
Table 127. GlaxoSmithKline 3D Printed Drugs SWOT Analysis
Table 128. GlaxoSmithKline Recent Developments
Table 129. Revolution Medicines Company Information
Table 130. Revolution Medicines Description and Overview
Table 131. Revolution Medicines 3D Printed Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 132. Revolution Medicines 3D Printed Drugs Product and Services
Table 133. Revolution Medicines 3D Printed Drugs SWOT Analysis
Table 134. Revolution Medicines Recent Developments
Table 135. FabRX Company Information
Table 136. FabRX Description and Overview
Table 137. FabRX 3D Printed Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 138. FabRX 3D Printed Drugs Product and Services
Table 139. FabRX 3D Printed Drugs SWOT Analysis
Table 140. FabRX Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. 3D Printed Drugs Distributors List
Table 144. 3D Printed Drugs Customers List
Table 145. 3D Printed Drugs Market Trends
Table 146. 3D Printed Drugs Market Drivers
Table 147. 3D Printed Drugs Market Challenges
Table 148. 3D Printed Drugs Market Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. 3D Printed Drugs Product Picture
Figure 2. Global 3D Printed Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global 3D Printed Drugs Market Share by Type in 2022 & 2034
Figure 4. Spritam Product Picture
Figure 5. Others Product Picture
Figure 6. Global 3D Printed Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global 3D Printed Drugs Market Share by Application in 2022 & 2034
Figure 8. Children
Figure 9. Elderly
Figure 10. Others
Figure 11. 3D Printed Drugs Report Years Considered
Figure 12. Global 3D Printed Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global 3D Printed Drugs Revenue 2018-2034 (US$ Million)
Figure 14. Global 3D Printed Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global 3D Printed Drugs Sales Quantity 2018-2034 (K Units)
Figure 16. Global 3D Printed Drugs Sales Quantity Market Share by Region (2018-2024)
Figure 17. Global 3D Printed Drugs Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America 3D Printed Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 19. North America 3D Printed Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe 3D Printed Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. Europe 3D Printed Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China 3D Printed Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. China 3D Printed Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC 3D Printed Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. APAC 3D Printed Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America 3D Printed Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America 3D Printed Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by 3D Printed Drugs Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by 3D Printed Drugs Revenue in 2022
Figure 30. 3D Printed Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global 3D Printed Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global 3D Printed Drugs Revenue Market Share by Type (2018-2034)
Figure 33. Global 3D Printed Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global 3D Printed Drugs Revenue Market Share by Application (2018-2034)
Figure 35. North America 3D Printed Drugs Revenue Market Share by Company in 2022
Figure 36. North America 3D Printed Drugs Sales Quantity Market Share by Company in 2022
Figure 37. North America 3D Printed Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America 3D Printed Drugs Revenue Market Share by Type (2018-2034)
Figure 39. North America 3D Printed Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America 3D Printed Drugs Revenue Market Share by Application (2018-2034)
Figure 41. North America 3D Printed Drugs Revenue Share by Country (2018-2034)
Figure 42. North America 3D Printed Drugs Sales Quantity Share by Country (2018-2034)
Figure 43. U.S. 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 44. Canada 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 45. Europe 3D Printed Drugs Sales Quantity Market Share by Company in 2022
Figure 46. Europe 3D Printed Drugs Revenue Market Share by Company in 2022
Figure 47. Europe 3D Printed Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe 3D Printed Drugs Revenue Market Share by Type (2018-2034)
Figure 49. Europe 3D Printed Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe 3D Printed Drugs Revenue Market Share by Application (2018-2034)
Figure 51. Europe 3D Printed Drugs Revenue Share by Country (2018-2034)
Figure 52. Europe 3D Printed Drugs Sales Quantity Share by Country (2018-2034)
Figure 53. Germany 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 54. France 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 56. Italy 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 57. Russia 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 58. China 3D Printed Drugs Sales Quantity Market Share by Company in 2022
Figure 59. China 3D Printed Drugs Revenue Market Share by Company in 2022
Figure 60. China 3D Printed Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 61. China 3D Printed Drugs Revenue Market Share by Type (2018-2034)
Figure 62. China 3D Printed Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 63. China 3D Printed Drugs Revenue Market Share by Application (2018-2034)
Figure 64. APAC 3D Printed Drugs Sales Quantity Market Share by Company in 2022
Figure 65. APAC 3D Printed Drugs Revenue Market Share by Company in 2022
Figure 66. APAC 3D Printed Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC 3D Printed Drugs Revenue Market Share by Type (2018-2034)
Figure 68. APAC 3D Printed Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC 3D Printed Drugs Revenue Market Share by Application (2018-2034)
Figure 70. APAC 3D Printed Drugs Revenue Share by Region (2018-2034)
Figure 71. APAC 3D Printed Drugs Sales Quantity Share by Region (2018-2034)
Figure 72. Japan 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 76. India 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America 3D Printed Drugs Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America 3D Printed Drugs Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America 3D Printed Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America 3D Printed Drugs Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America 3D Printed Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America 3D Printed Drugs Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America 3D Printed Drugs Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America 3D Printed Drugs Revenue Share by Country (2018-2034)
Figure 85. Brazil 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 88. Israel 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries 3D Printed Drugs Revenue (2018-2034) & (US$ Million)
Figure 90. 3D Printed Drugs Value Chain
Figure 91. 3D Printed Drugs Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed